Evidence map›Paper›PMID 35379629›Full record

Observational studyBMJ open2022

Association between proteinuria and incident colorectal cancer: analysis of a nationwide population-based database.

Satoshi Matsuoka, Hidehiro Kaneko, Akira Okada, Akira Fukui, Yuichiro Yano, Hidetaka Itoh, Kojiro Morita, Katsuhito Fujiu, Nobuaki Michihata, Taisuke Jo and 11 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Urinary albumin excretion and cancer risk: the PREVEND cohort study.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2023
    Observational
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 8 institutions in 4 countries.

Satoshi MatsuokaThe Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.
Hidehiro KanekoThe Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan kanekohidehiro@gmail.com.ORCID 0000-0003-2553-6170
Akira OkadaDepartment of Prevention of Diabetes and Lifestyle-Related Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Akira FukuiDivision of Nephrology and Hypertension, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
Yuichiro YanoYCU Center for Novel and Exploratory Clinical Trials, Yokohama City University Hospital, Yokohama, Japan.
Hidetaka ItohThe Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.
Kojiro MoritaGlobal Nursing Research Center, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Katsuhito FujiuThe Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.
Nobuaki MichihataThe Department of Health Services Research, The University of Tokyo, Tokyo, Japan.
Taisuke JoThe Department of Health Services Research, The University of Tokyo, Tokyo, Japan.
Norifumi TakedaThe Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.
Hiroyuki MoritaThe Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.
Satoko YamaguchiDepartment of Prevention of Diabetes and Lifestyle-Related Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Sunao NakamuraDepartment of Cardiology, New Tokyo Hospital, Matsudo, Japan.
Akira NishiyamaDepartment of Pharmacology, Faculty of Medicine, Kagawa University, Kagawa, Japan.
Takashi YokooDivision of Nephrology and Hypertension, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
Koichi NodeDepartment of Cardiovascular Medicine, Saga University, Saga, Japan.
Toshimasa YamauchiDepartment of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Masaomi NangakuDivision of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Hideo YasunagaThe Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan.
Issei KomuroThe Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.
The University of Tokyo · JPJikei University School of Medicine · JPNew Tokyo Hospital · JPDiabetes Australia · AUDuke University · USFaculty of Public Health · GBKagawa University · JPSaga University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study aimed to assess whether adults with proteinuria were at a higher risk of incident colorectal cancer (CRC) than those without proteinuria using a large-scale population-based database.

designA retrospective observational study.

settingThe JMDC Claims Database, an administrative health claims database, was used. Data were collected between 2005 and 2020.

participantsWe selected records of participants (n=3 543 705) who underwent health check-ups, including physical examinations, blood tests and urine dipstick tests. We excluded participants who were aged <20 years (n=25 577), had a history of CRC, colorectal disease, renal disease and renal replacement therapy (n=114 888), or had missing data on medications (n=170 145), cigarette smoking (n=14 835), alcohol consumption (n=366 414) or physical activity (n=106 550). Finally, we analysed 2 745 296 participants.

main outcome measuresThe primary outcome was CRC at any stage.

resultsParticipants were categorised as having no proteinuria (n=2 435 872), trace proteinuria (n=231 153) or positive proteinuria (n=78 271). Over a mean follow-up period of 1189±914 days, 10 615 CRC diagnoses were recorded. The incidence of CRC (95% CI) was lowest in participants without proteinuria (11.7; 95% CI, 11.5 to 11.9 per 10 000 person-years), followed by trace proteinuria (12.5; 95% CI, 11.7 to 13.3 per 10 000 person-years) and positive proteinuria (16.1; 95% CI, 14.6 to 17.7 per 10 000 person-years). After multivariable adjustment, compared with no proteinuria, HRs for incident CRC were 1.20 (95% CI, 1.12 to 1.29) and 1.23 (95% CI, 1.11 to 1.36) for trace and positive proteinuria, respectively. The association between proteinuria and incident CRC existed in participants after multiple imputations for missing data, with a follow-up period of ≥365 days, regardless of age, sex, obesity, hypertension, diabetes mellitus and estimated glomerular filtration rate.

conclusionsTrace and positive proteinuria were associated with a greater risk of incident CRC. Assessment of proteinuria could help identify individuals at an increased risk of CRC.

Indexed as

Colorectal NeoplasmsHypertensionAdultGlomerular Filtration RateHumansProteinuriaRisk FactorsYoung AdultEpidemiologyNephrologyONCOLOGYPREVENTIVE MEDICINE

Identifiers

PMID35379629
PMCPMC8981279
OpenAlexW4224323682

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.